Marcin Krawczyk
Overview
Explore the profile of Marcin Krawczyk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
188
Citations
2525
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arechederra M, Bik E, Rojo C, Elurbide J, Elizalde M, Kruk B, et al.
Liver Int
. 2025 Mar;
45(4):e70049.
PMID: 40029142
Background: Primary sclerosing cholangitis (PSC) is a chronic liver disease characterised by inflammation and fibrosis of the bile ducts, conferring an increased risk of cholangiocarcinoma (CCA). However, detecting CCA early...
2.
Krupa L, Portincasa P, Lammert F, Krawczyk M
Pol Arch Intern Med
. 2025 Jan;
135(1).
PMID: 39882680
No abstract available.
3.
Weber S, Lambert I, Lammert F, Krawczyk M
Intern Emerg Med
. 2025 Jan;
PMID: 39786488
Gallstones are among the most frequent hepatobiliary conditions. Although in most cases, they remain asymptomatic, they can cause complications and, in such cases, invasive treatments like endoscopic retrograde cholangiography (ERC)...
4.
Krupa L, Lammert F, Krawczyk M
Ann Hepatol
. 2024 Dec;
30(1):101752.
PMID: 39631460
No abstract available.
5.
Schmartz G, Rehner J, Gund M, Keller V, Molano L, Rupf S, et al.
Nat Commun
. 2024 Sep;
15(1):8261.
PMID: 39327438
The human microbiome emerges as a promising reservoir for diagnostic markers and therapeutics. Since host-associated microbiomes at various body sites differ and diseases do not occur in isolation, a comprehensive...
6.
Schmartz G, Rehner J, Schuff M, Molano L, Becker S, Krawczyk M, et al.
Nat Commun
. 2024 Sep;
15(1):8263.
PMID: 39327429
Understanding human, animal, and environmental microbiota is essential for advancing global health and combating antimicrobial resistance (AMR). We investigate the oral and gut microbiota of 48 animal species in captivity,...
7.
Elurbide J, Colyn L, Latasa M, Uriarte I, Mariani S, Lopez-Pascual A, et al.
Gut
. 2024 Sep;
74(1):116-127.
PMID: 39266051
Background: Cholangiocarcinoma (CCA) is a very difficult-to-treat cancer. Chemotherapies are little effective and response to immune checkpoint inhibitors is limited. Therefore, new therapeutic strategies need to be identified. Objective: We...
8.
Krupa L, Smyk W, Staron R, Niemiec E, Jadwisiak A, Milkiewicz P, et al.
J Palliat Med
. 2024 Aug;
27(11):1475-1481.
PMID: 39093125
Endosonography-guided biliary drainage (EUS-BD) serves as a rescue treatment modality for patients with malignant biliary obstruction when endoscopic retrograde cholangiopancreatography (ERCP) fails. This study explores the effects of EUS-BD on...
9.
Roeb E, Canbay A, Bantel H, Bojunga J, de Laffolie J, Demir M, et al.
Z Gastroenterol
. 2024 Jul;
62(7):1077-1087.
PMID: 38976985
No abstract available.
10.
Lopens S, Schierack P, Krause J, Piaszczynski M, Krol R, Staron R, et al.
Clin Chim Acta
. 2024 Jul;
562:119841.
PMID: 38964568
Background: Glycoprotein-2 (GP2) IgA is a predictor of disease severity in primary sclerosing cholangitis (PSC). We examined GP2's occurrence in the biliary tract, the site of inflammation. Methods: GP2 was...